Zeruesenay Desta

Title: Innovations of Zeruesenay Desta

Introduction

Zeruesenay Desta is an accomplished inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmacogenomics, particularly in evaluating enzyme activity related to drug metabolism. His innovative approach has the potential to enhance personalized medicine.

Latest Patents

Zeruesenay Desta holds a patent for "Methods to evaluate cytochrome P450 2C19 isoenzyme activity using a breath test." This invention relates to a method of determining and assessing cytochrome P450 2C19-related (CYP2C19) metabolic capacity in an individual mammalian subject via a breath assay. The method involves determining the relative amount of carbon monoxide (CO) exhaled by the subject upon intravenous or oral administration of a carbon-labeled CYP2C19 substrate compound. This non-invasive, in vivo assay is useful for evaluating CYP2C19 enzyme activity in a subject using the metabolite CO in expired breath. It aids in phenotyping individual subjects and determining the selection, optimal dosage, and timing of drug administration.

Career Highlights

Zeruesenay Desta has made notable strides in his career, particularly through his work at Cambridge Isotope Laboratories, Inc. His research focuses on improving drug efficacy and safety by understanding individual metabolic responses. His innovative methods have garnered attention in the scientific community.

Collaborations

Zeruesenay has collaborated with esteemed colleagues such as David A. Flockhart and Anil S. Modak. These collaborations have furthered research in pharmacogenomics and contributed to advancements in personalized medicine.

Conclusion

Zeruesenay Desta's contributions to the field of pharmacogenomics through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work exemplifies the importance of personalized medicine in optimizing drug therapy.